CYCC
Cyclacel Pharmaceuticals Inc
NASDAQ: CYCC · HEALTHCARE · BIOTECHNOLOGY
$6.37
+0.00% today
Updated 2026-04-29
Market cap
$14.25M
P/E ratio
0.00
P/S ratio
1,425.11x
EPS (TTM)
$7,123.50
Dividend yield
—
52W range
$3 – $98
Volume
—
Cyclacel Pharmaceuticals Inc (CYCC) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |